The Global Sucralose for Pharmaceutical Grade Market is forecast to reach USD 6.11 Billion by 2027, according to a new report by Reports and Data. Increasing awareness about the adverse impact of consuming excesses amount of added sugar on the metabolism and overall health of an individual is an integral factor, opening various venues for expansion of the Sucralose for Pharmaceutical Grade Market. Such awareness among the consumers has resulted in elevating preference for artificial sweeteners like sucralose, which has zero-calorie. One of the most common sucralose-based product is Splenda. This type of artificial sweetener is 400–700 times sweeter than sugar, and it is considered to be safe for the consumption of diabetic patients. Unlike many other popular sweeteners, it does not have a bitter aftertaste. Thus, the rising incidence rate of diabetes and elevating focus of the food & beverage industry on expanding their product line and making those products appropriate for diabetic patients is supporting the growth of the sector. The favorable comparison of this artificial sweetener with other low-calorie sweeteners in terms of stability, taste, and is one of the major reasons for its commercial success.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2673
Top Companies Operating in the Global Sucralose for Pharmaceutical Grade Market Report:
Bioplus Life Sciences, JK Sucralose Inc., Unitech Sweet (Zibo) Ltd., Nantong Changhai Food Additive Co. Ltd., Xiamen Boao Technology, Unitech Sweet (Zibo) Ltd., Jiangsu Jubang Pharmaceutical Co., Ltd., L&P Food Ingredient Co., Ltd., Ji'an New Trend Technology Co., Ltd., Vitasweet co. ltd., and Heartland Food Products Group.
Further key findings from the report suggest
- The Sucralose for Pharmaceutical Grade Market held a market share of USD 3.86 Billion in the year 2018 that is forecasted to grow at a rate of 5.2% during the forecast period.
- In context to Form, the Granular segment is projected to witness a significant growth rate of 5.6% during the forecast period, which is expected to hold 33.0% of the market by 2027. The growth rate witnessed by the Granular segment is attributed to the increasing demand for the artificial sweetener in the granular form in various sectors like the pharmaceutical industry and in animal feeds, which is supporting the growth rate witnessed by this segment.
- In context to Grade, the Food grade segment held the largest market share of more than 55.0% in 2018, with a CAGR of 5.4% during the forecast period. The market share held by the Food grade segment is attributed to the continuous expansion of the food industry, the rising incidence rate of diabetes and elevating focus of food sector on expanding their product line and making their products appropriate for diabetic patients, which results in elevated used of this type of artificial sweeteners in various food products like pastries, sugar free cakes, contributing to the market share held by this segment.
- In regards to Application, the Drugs segment is projected to witness the fastest growth rate of 5.9% during the forecast period, which is expected to hold 17.0% of the market by 2027. The growth rate witnessed by the Drug segment is attributed to the continuous growth of the pharmaceutical sector, effective masking capacity of the bitterness of various medications by this type of artificial sweetener without effecting its properties and medical off-notes with ease contributes to the elevating use of this type of sweeteners in pharmaceuticals.
- In regards to the region, Asia Pacific is projected to witness the fastest CAGR of 5.7% during the forecast period, which is expected to hold 24.0% of the market by 2027. The growth rate witnessed by the APAC region is attributed to the continuous growth of the food & beverage sector, high demand for animal feeds and expanding pharmaceutical industry along with increasing incidence rate of diabetes, which is supporting the expansion of the sector in this region.
To read more about the report @ https://www.reportsanddata.com/report-detail/sucralose-market
The global Sucralose for Pharmaceutical Grade Market is segmented into:
- North America (U.S.A., Canada, Mexico)
- Europe (Italy, U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Further market segmentation
Form Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2027)
- Powder
- Granular
- Liquid
- Others
Grade Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2027)
- Food Grade
- Pharmaceutical Grade
- Others
Application Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2027)
- Food
- Beverages
- Animal feed
- Drugs
- Others
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2673
Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blog: https://www.reportsanddata.com/blogs